MetaADEDB 2.0 @ LMMD
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide
(WROHEWWOCPRMIA-UHFFFAOYSA-N)
Structure
SMILES
CNC(=O)c1ccc(nc1)Oc1ccc2c(c1)CCN(CC2)C1CCC1
Molecular Formula:
C21H25N3O2
Molecular Weight:
351.442
Log P:
3.5154
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
54.46
CAS Number(s):
720690-73-3; 854485-15-7
Synonym(s)
1.
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide
2.
GSK 189254
3.
GSK-189254
4.
GSK189254
External Link(s)
MeSHC521312
PubChem Compound9798547
BindingDB50247054
CHEMBLCHEMBL517140
IUPHAR/BPS Guide to PHARMACOLOGY10736
Therapeutic Target DatabaseD0H4TP
ZINC3961799
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Amnesia19657331CTD
2Cognition Disorders21634396CTD
3Narcolepsy21634396CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.